Your Pharmacy Toolkit.
From 5 November 2026, nurse practitioners in NSW may seek NSW Health approval to prescribe, supply or administer Schedule 8 psychostimulant medicines, subject to certain conditions.
Novo Nordisk and Eli Lilly are withdrawing multiple insulin presentations from the Australian market between 2024 and 2026, with ACSQHC transition fact sheets now available.
ASCIA has released new adult penicillin allergy guidelines to help GPs assess reported allergies and identify patients suitable for oral penicillin challenges.
The TGA has approved expanded indications for MS-2 Step, extending medical termination to 70 days' gestation and adding a new indication for missed miscarriage management.
The Australian Government has announced $98.1 million in Medical Research Future Fund funding across three 2026 grant opportunities covering disability health, implementation research and research translation.
